Capture of an early fusion-active conformation of HIV-1 gp41

Nat Struct Biol. 1998 Apr;5(4):276-9. doi: 10.1038/nsb0498-276.

Abstract

Using an inhibitory synthetic peptide (DP-178) from HIV-1 gp41, we have trapped HIV-1 envelope glycoprotein (Env) undergoing conformational changes during virus entry. Our data show that DP-178 binds gp41 and inhibits Env-mediated membrane fusion after gp120 interacts with cellular receptors, indicating that conformational changes involving the coiled coil domain of gp41 are required for entry. Capture of this fusion-active conformation of Env provides insights into the early events leading to Env-mediated membrane fusion.

MeSH terms

  • 3T3 Cells
  • Amino Acid Sequence
  • Animals
  • Anti-HIV Agents / pharmacology
  • Cell Fusion / drug effects
  • Cell Line
  • Enfuvirtide
  • HIV Envelope Protein gp41 / chemistry*
  • HIV Envelope Protein gp41 / metabolism*
  • HIV Envelope Protein gp41 / pharmacology
  • HIV-1 / drug effects
  • HIV-1 / physiology*
  • Humans
  • Membrane Fusion / drug effects
  • Membrane Fusion / physiology*
  • Mice
  • Models, Biological
  • Models, Molecular
  • Molecular Sequence Data
  • Peptide Fragments / pharmacology
  • Protein Conformation*
  • Receptors, Chemokine / drug effects
  • Receptors, Chemokine / physiology
  • Receptors, HIV / drug effects
  • Receptors, HIV / physiology
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / metabolism
  • Transfection

Substances

  • Anti-HIV Agents
  • HIV Envelope Protein gp41
  • Peptide Fragments
  • Receptors, Chemokine
  • Receptors, HIV
  • Recombinant Fusion Proteins
  • Enfuvirtide